Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

668
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
668
Vaccinations01:51

Vaccinations

49.2K
Overview
49.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of L-Amino Acid Oxidase (Ml-LAAO) from the Venom of the <i>Micrurus lemniscatus</i> Snake in a Mammalian Cell System.

Toxins·2025
Same author

Pre-clinical studies of Schistosoma mansoni vaccines: A scoping review.

PLoS neglected tropical diseases·2025
Same author

Salidroside Ameliorates Lung Injury Induced by PM <sub>2.5</sub>by Regulating SIRT1-PGC-1α in Mice.

Biomedical and environmental sciences : BES·2024
Same author

Antigenic epitope targets of rhesus macaques self-curing from <i>Schistosoma mansoni</i> infection.

Frontiers in immunology·2024
Same author

Comparative analysis of Chrysoporthe cubensis exoproteomes and their specificity for saccharification of sugarcane bagasse.

Enzyme and microbial technology·2023
Same author

Models of Protective Immunity against Schistosomes: Implications for Vaccine Development.

Pathogens (Basel, Switzerland)·2023

Related Experiment Video

Updated: Nov 19, 2025

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

17.9K

Schistosome vaccines: problems, pitfalls and prospects.

R Alan Wilson1, Xiao Hong Li2, William Castro-Borges3

  • 1Centre for Immunology and Infection, Department of Biology, University of York, York YO26 6JB, U.K.

Emerging Topics in Life Sciences
|February 2, 2021
PubMed
Summary

Developing a vaccine for human schistosomiasis (schistosomiasis) is challenging due to parasite immune evasion. Promising new vaccine candidates target parasite proteins at the host interface, particularly esophageal gland proteins.

Keywords:
Schistosomaantigenesophageal glandparasite–host interfacerhesus macaquevaccine

More Related Videos

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.2K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.8K

Related Experiment Videos

Last Updated: Nov 19, 2025

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

17.9K
A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.2K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.8K

Area of Science:

  • Parasitology
  • Immunology
  • Vaccinology

Background:

  • Human schistosomiasis remains a significant global health issue, primarily managed through chemotherapy.
  • The development of an effective vaccine against schistosomiasis is crucial but has faced considerable hurdles.
  • Current control strategies are insufficient, highlighting the need for novel interventions.

Purpose of the Study:

  • To review the reasons for the lack of progress in schistosomiasis vaccine development.
  • To identify promising new avenues for vaccine research and development.
  • To evaluate novel vaccine candidates based on parasite-host interface proteins.

Main Methods:

  • Review of existing literature on schistosomiasis vaccine research.
  • Analysis of parasite immune evasion strategies.
  • Evaluation of recent findings in non-human primate models and identification of key parasite antigens.

Main Results:

  • Obstacles to vaccine development include parasite immune evasion, historical research misdirections, focus on internal antigens, and limitations of mouse models.
  • Rhesus macaque self-cure studies offer a promising model for vaccine development.
  • Proteins at the parasite-host interface, especially esophageal gland proteins involved in blood processing, represent a new class of vaccine candidates.

Conclusions:

  • Revisiting vaccine development strategies and focusing on parasite-host interface proteins, particularly those from esophageal glands, is essential for advancing schistosomiasis vaccine research.
  • The rhesus macaque model shows potential for evaluating novel vaccine candidates.
  • Targeting specific parasite proteins offers a more promising path toward an effective schistosomiasis vaccine.